相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities
Joaquim Soler et al.
PSYCHOPHARMACOLOGY (2016)
Ayahuasca: Pharmacology, neuroscience and therapeutic potential
Elisabet Dominguez-Clave et al.
BRAIN RESEARCH BULLETIN (2016)
Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution
Enzo Tagliazucchi et al.
CURRENT BIOLOGY (2016)
Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans
Marta Valle et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
LSD-Induced Entropic Brain Activity Predicts Subsequent Personality Change
A. V. Lebedev et al.
HUMAN BRAIN MAPPING (2016)
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression A SPECT Study
Rafael Faria Sanches et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
Patrick C. Dolder et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Effects of serotonin 2A/1A receptor stimulation on social exclusion processing
Katrin H. Preller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The paradoxical psychological effects of lysergic acid diethylamide (LSD)
R. L. Carhart-Harris et al.
PSYCHOLOGICAL MEDICINE (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Yasmin Schmid et al.
BIOLOGICAL PSYCHIATRY (2015)
Phosphene Perception Relates to Visual Cortex Glutamate Levels and Covaries with Atypical Visuospatial Awareness
Devin B. Terhune et al.
CEREBRAL CORTEX (2015)
Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans
Jose Carlos Bouso et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Increase in glutamate/glutamine concentration in the medial prefrontal cortex during mental imagery: A combined functional mrs and fMRI study
Zirui Huang et al.
HUMAN BRAIN MAPPING (2015)
Acute Biphasic Effects of Ayahuasca
Eduardo Ekman Schenberg et al.
PLOS ONE (2015)
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flavia de L. Osorio et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2015)
Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study
Jordi Riba et al.
DRUG TESTING AND ANALYSIS (2015)
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
Fernanda Palhano-Fontes et al.
PLOS ONE (2015)
The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice
Theresa M. Carbonaro et al.
PSYCHOPHARMACOLOGY (2015)
Evidence for rostro-caudal functional organization in multiple brain areas related to goal-directed behavior
Matthew L. Dixon et al.
BRAIN RESEARCH (2014)
Validation of the Spanish versions of the long (26 items) and short (12 items) forms of the Self-Compassion Scale (SCS)
Javier Garcia-Campayo et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2014)
Enhanced Repertoire of Brain Dynamical States During the Psychedelic Experience
Enzo Tagliazucchi et al.
HUMAN BRAIN MAPPING (2014)
A Guide to the Metabolic Pathways and Function of Metabolites Observed in Human Brain H-1 Magnetic Resonance Spectra
Caroline D. Rae
NEUROCHEMICAL RESEARCH (2014)
Relationship between Meditative Practice and Self-Reported Mindfulness: The MINDSENS Composite Index
Joaquim Soler et al.
PLOS ONE (2014)
Decreased Occipital Cortical Glutamate Levels in Response to Successful Cognitive-Behavioral Therapy and Pharmacotherapy for Major Depressive Disorder
Chadi G. Abdallah et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2014)
Assessing Decentering: Validation, Psychometric Properties, and Clinical Usefulness of the Experiences Questionnaire in a Spanish Sample
Joaquim Soler et al.
BEHAVIOR THERAPY (2014)
Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on α Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations
Michael Kometer et al.
JOURNAL OF NEUROSCIENCE (2013)
Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis
Robin L. Carhart-Harris et al.
SCHIZOPHRENIA BULLETIN (2013)
Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion
Draulio B. de Araujo et al.
HUMAN BRAIN MAPPING (2012)
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Enhancement of Creative Expression and Entoptic Phenomena as After-Effects of Repeated Ayahuasca Ceremonies
Ede Frecska et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2012)
Conn: A Functional Connectivity Toolbox for Correlated and Anticorrelated Brain Networks
Susan Whitfield-Gabrieli et al.
BRAIN CONNECTIVITY (2012)
Psychometric properties of the Spanish validation of the Five Facets of Mindfulness Questionnaire (FFMQ)
A. Cebolla et al.
EUROPEAN JOURNAL OF PSYCHIATRY (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Default-Mode and Task-Positive Network Activity in Major Depressive Disorder: Implications for Adaptive and Maladaptive Rumination
J. Paul Hamilton et al.
BIOLOGICAL PSYCHIATRY (2011)
Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists
Jose L. Moreno et al.
NEUROSCIENCE LETTERS (2011)
Meditation experience is associated with differences in default mode network activity and connectivity
Judson A. Brewer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R. Griffiths et al.
PSYCHOPHARMACOLOGY (2011)
OPINION The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Development of Anterior Cingulate Functional Connectivity from Late Childhood to Early Adulthood
A. M. Clare Kelly et al.
CEREBRAL CORTEX (2009)
Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry
Ethan H. McIlhenny et al.
JOURNAL OF CHROMATOGRAPHY A (2009)
Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression
Christina L. Fales et al.
BIOLOGICAL PSYCHIATRY (2008)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Sustained neuronal activation raises oxidative metabolism to a new steady-state level:: evidence from 1H NMR spectroscopy in the human visual cortex
Silvia Mangia et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Reduction in occipital cortex γ-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects
Zubin Bhagwagar et al.
BIOLOGICAL PSYCHIATRY (2007)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant
J Riba et al.
PSYCHOPHARMACOLOGY (2006)
The human brain is intrinsically organized into dynamic, anticorrelated functional networks
MD Fox et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex
JW Muschamp et al.
BRAIN RESEARCH (2004)
Effects of the South American psychoactive beverage Ayahuasca on regional brain electrical activity in humans: A functional neuroimaging study using low-resolution electromagnetic tomography
J Riba et al.
NEUROPSYCHOBIOLOGY (2004)
Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy
BSY Li et al.
MAGNETIC RESONANCE IMAGING (2003)
The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats
JL Scruggs et al.
NEUROSCIENCE LETTERS (2003)
Human pharmacology of ayahuasca: Subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics
J Riba et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice
A Klodzinska et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers
J Riba et al.
PSYCHOPHARMACOLOGY (2001)
A default mode of brain function
ME Raichle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)